Johnson Market Capitalization from 2010 to 2024

JNJ Stock  USD 149.60  0.29  0.19%   
Johnson Johnson Market Cap yearly trend continues to be relatively stable with very little volatility. Market Cap may rise above about 183.4 B this year.
Check Johnson Johnson financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Johnson Johnson's main balance sheet or income statement drivers, such as Depreciation And Amortization of 7.9 B, Interest Expense of 1.3 B or Total Revenue of 49.3 B, as well as many indicators such as Price To Sales Ratio of 2.83, Dividend Yield of 0.0177 or PTB Ratio of 5.86. Johnson financial statements analysis is a perfect complement when working with Johnson Johnson Valuation or Volatility modules.
  
Check out the analysis of Johnson Johnson Correlation against competitors.
For more information on how to buy Johnson Stock please use our How to buy in Johnson Stock guide.

Latest Johnson Johnson's Market Capitalization Growth Pattern

Below is the plot of the Market Cap of Johnson Johnson over the last few years. It is Johnson Johnson's Market Cap historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Johnson Johnson's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 360.18 B10 Years Trend
Slightly volatile
   Market Cap   
       Timeline  

Johnson Market Capitalization Regression Statistics

Arithmetic Mean181,524,218,824
Geometric Mean171,380,544,609
Coefficient Of Variation22.51
Mean Deviation20,423,169,273
Median194,074,218,113
Standard Deviation40,854,314,178
Sample Variance1669074986.9T
Range159.6B
R-Value0.36
Mean Square Error1566595908.6T
R-Squared0.13
Significance0.19
Slope3,273,979,124
Total Sum of Squares23367049816.8T

Johnson Market Capitalization History

2024183.4 B
2023174.7 B
2012194.1 B
2011194.8 B
201035.2 B

About Johnson Johnson Financial Statements

Investors use fundamental indicators, such as Johnson Johnson's Market Capitalization, to determine how well the company is positioned to perform in the future. Although Johnson Johnson's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Johnson Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company was founded in 1886 and is based in New Brunswick, New Jersey. Johnson Johnson operates under Drug ManufacturersGeneral classification in the United States and is traded on New York Stock Exchange. It employs 141700 people.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Johnson Johnson is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Johnson Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Johnson Johnson Stock. Highlighted below are key reports to facilitate an investment decision about Johnson Johnson Stock:
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Johnson Johnson. If investors know Johnson will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Johnson Johnson listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.89)
Dividend Share
4.86
Earnings Share
6.05
Revenue Per Share
36.428
Quarterly Revenue Growth
0.052
The market value of Johnson Johnson is measured differently than its book value, which is the value of Johnson that is recorded on the company's balance sheet. Investors also form their own opinion of Johnson Johnson's value that differs from its market value or its book value, called intrinsic value, which is Johnson Johnson's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Johnson Johnson's market value can be influenced by many factors that don't directly affect Johnson Johnson's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Johnson Johnson's value and its price as these two are different measures arrived at by different means. Investors typically determine if Johnson Johnson is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Johnson Johnson's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.